CVR number 38051040
Industry 32.5000 Manufacture of medical and dental instruments and supplies

Ortopædisk Håndskomageri Lars Nielsen ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  1.9% 1.0% 1.2% 1.1% 1.9%  
Credit score (0-100)  71 85 80 83 69  
Credit rating  A A A A A  
Credit limit (kDKK)  0.3 74.2 25.9 31.0 0.9  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  1,795 2,102 1,782 1,891 1,646  
EBITDA  775 1,263 756 796 425  
EBIT  684 811 555 628 101  
Pre-tax profit (PTP)  619.7 897.6 221.1 304.9 -265.4  
Net earnings  481.4 696.3 168.7 233.6 -193.5  
Pre-tax profit without non-rec. items  620 898 221 305 -265  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  3,948 7,461 8,505 9,740 14,418  
Shareholders equity total  552 748 237 290 2,322  
Interest-bearing liabilities  2,826 7,749 9,149 9,385 11,365  
Balance sheet total (assets)  4,445 8,993 9,974 10,177 14,912  
Net Debt  2,674 6,642 8,040 9,269 11,197  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,795 2,102 1,782 1,891 1,646  
Gross profit growth  12.8% 17.1% -15.2% 6.1% -12.9%  
Employees  3 3 2 2 3  
Employee growth %  50.0% 0.0% -33.3% 0.0% 50.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,445 8,993 9,974 10,177 14,912  
Balance sheet change%  201.6% 102.3% 10.9% 2.0% 46.5%  
Added value  774.7 1,262.9 756.3 829.4 424.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  3,727 3,042 837 1,068 1,888  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  38.1% 38.6% 31.2% 33.2% 6.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  23.6% 16.1% 5.9% 6.3% 0.8%  
ROI %  32.6% 18.2% 6.3% 6.6% 0.8%  
ROE %  94.2% 107.2% 34.3% 88.7% -14.8%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  12.4% 8.3% 2.4% 2.9% 52.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  345.2% 526.0% 1,063.0% 1,164.9% 2,636.0%  
Gearing %  512.4% 1,036.1% 3,867.3% 3,234.1% 489.4%  
Net interest  0 0 0 0 0  
Financing costs %  4.8% 3.5% 4.0% 3.5% 3.5%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.1 0.3 0.2 0.1 0.1  
Current Ratio  0.1 0.3 0.2 0.1 0.1  
Cash and cash equivalent  152.2 1,106.8 1,109.1 115.9 167.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -3,408.6 -3,925.3 -4,544.2 -6,604.0 -3,154.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  258 421 378 415 142  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  258 421 378 398 142  
EBIT / employee  228 270 278 314 34  
Net earnings / employee  160 232 84 117 -65